The biosynthesis of camalexin, the main phytoalexin of the model plant Arabidopsis thaliana, involves at least two CYP (cytochrome P450) steps. It is synthesized from tryptophan via indole-3-acetaldoxime in a reaction catalysed by CYP79B2 and CYP79B3. Based on the pad3 mutant phenotype, CYP71B15 (PAD3) had also been suggested as a camalexin biosynthetic gene. CYP71B15 catalyses the final step in camalexin biosynthesis, as recombinant CYP71B15 and microsomes from Arabidopsis leaves expressing functional PAD3 converted dihydrocamalexic acid into camalexin. The biosynthetic pathway is co-ordinately induced, strictly localized to the site of pathogen infection. This provides a model system to study the regulation of CYP enzymes involved in phytoalexin biosynthesis.
CYP79B2/CYP79B3 catalyse the first step of camalexin biosynthesis from tryptophan
In early experiments, the biosynthetic origin of camalexin was addressed by in vivo feeding of labelled anthranilate, indole and tryptophan and by the analysis of tryptophan biosynthetic mutants [3] . As indole was most efficiently incorporated into camalexin, a tryptophan-independent biosynthesis was concluded and it was suggested that a tryptophan synthase α-subunit homologue, such as BX1 from maize [4] , catalyses the formation of indole in camalexin biosynthesis [5] . Alternatively, a biosynthetic origin from IAOx (indole-3-acetaldoxime) was possible, as IAOx was shown to be a precursor of brassinin and brassinin-derived phytoalexins, which are structurally related to camalexin [6] .
CYP (cytochrome P450) enzymes of the 79 family convert amino acids into the corresponding oximes as key steps in the biosynthesis of cyanogenic glucosides and glucosinolates (reviewed in [7] ). CYP79B2 and CYP79B3 from Arabidopsis specifically accepted tryptophan as the substrate, which was Key words: Arabidopsis, biosynthesis, camalexin, CYP79B2, pad3, phytoalexin. Abbreviations used: CYP, cytochrome P450; GUS, β-glucuronidase; IAOx, indole-3-acetaldoxime; ROS, reactive oxygen species; RT, reverse transcriptase. 1 email egl@wzw.tum.de converted into IAOx [8, 9] . IAOx is an essential intermediate of indole glucosinolate biosynthesis, as cyp79b2/cyp79b3 insertion mutants are devoid of indole glucosinolates [10] . To investigate whether tryptophan-derived IAOx and not indole is the biosynthetic origin of camalexin, labelled IAOx was applied to Arabidopsis leaves induced with silver nitrate. Efficient incorporation into camalexin was observed [11] . The presence of either functional CYP79B2 or CYP79B3 was essential for camalexin formation. No camalexin was detected in cyp79b2/cyp79b3 mutants after silver nitrate induction and Botrytis cinereae infection [11, 12] . This demonstrated that, despite low incorporation of labelled tryptophan, camalexin is in fact tryptophan-derived, which is converted into IAOx by CYP79B enzymes (Scheme 1).
It has been hypothesized that cruciferous indole phytoalexins derive from indole glucosinolates [13] . However, camalexin is induced in the mutant sur1 that is completely blocked in its biosynthesis of glucosinolates [11, 14] . The establishment of IAOx as the likely metabolic branch point between indole glucosinolate and camalexin biosynthesis implied that the IAOx-metabolizing enzyme in the camalexin biosynthetic pathway has to compete for its substrate with CYP83B1, a CYP that efficiently channels IAOx into the indole glucosinolate biosynthetic pathway [15] . The IAOxmetabolizing steps in camalexin biosynthesis have not yet been characterized. Possibly, the IAOx side chain is shortened by one carbon in an additional CYP-catalysed reaction, forming the substrate for conjugation with cysteine or a cysteine metabolite. Finally, dihydrocamalexic acid is formed, an intermediate that rescues the camalexin-deficient phenotype of cyp79b2/cyp79b3 knockout mutants [16] .
CYP71B15 (PAD3) catalyses the final step in camalexin biosynthesis
The pad3 mutant was isolated in a screen for camalexin-deficient mutants [17] and proved to contain very low camalexin
Scheme 1 The camalexin biosynthetic pathway
The camalexin biosynthetic pathway, involving two steps catalysed by the CYP enzymes CYP79B2/B3 and CYP71B15, and related pathways are shown. TSA, TSB, tryptophan synthase α-and β-subunits respectively; SUR1, CS lyase encoded by superroot1; Cys-R: cysteine or cysteine-metabolite. levels independent of the inducing pathogen, indicating an essential role in the biosynthesis. It accumulated dihydrocamalexic acid in root cultures [18] and rosette leaves challenged with silver nitrate [16] . The PAD3 gene was cloned and encodes CYP71B15 [19] . CYP71B15 was expressed in yeast, and after incubation of the microsomes with dihydrocamalexic acid, NADPH-dependent camalexin formation was observed. Both enantiomers of dihydrocamalexic acid were metabolized to camalexin, but the (S)-enantiomer, derived from the natural L-cysteine, was preferred and a K m (app) of 27 µM was determined. For this unusual reaction that results in simultaneous decarboxylation and introduction of a C-C double bond, a mechanistic model was proposed: quinquivalent oxoiron in the reaction centre of CYP71B15 initially abstracts a hydride ion from C-5 of the thiazole ring. Then, in a spontaneous process, carbon dioxide is liberated and a C4-C5 double bond in the thiazole ring of camalexin is formed [16] . Arabidopsis microsomes isolated from leaves of CYP71B15-overexpressing and induced wild-type plants were capable of the same reaction, but not microsomes from induced leaves of pad3 mutants, confirming that CYP71B15 (PAD3) catalyses the final step in camalexin biosynthesis [16] (Scheme 1).
Regulation of the camalexin biosynthetic genes
While many defence compounds are induced by a jasmonate or salicylate, these signalling compounds are not essential for camalexin induction. Possibly several input signals are integrated to trigger camalexin biosynthesis. This is supported by the observed lack of correlation between ecotype variation of camalexin concentration after different treatments [20, 21] . No clear general 'high-camalexin' or 'low-camalexin' ecotypes were detected. One signal important for camalexin induction is the formation of ROS (reactive oxygen species). The esa1 mutant, identified in a screen for enhanced susceptibility to Alternaria, synthesized consistently low camalexin levels, particularly in response to ROS-inducing agents [22] . Accordingly, the ups1 mutant, which synthesizes reduced camalexin levels, was defective in induction of ROSinduced genes and genes of the tryptophan and camalexin biosynthetic pathway [23] .
In general, phytoalexin formation is a non-systemic process and local induction of phytoalexin biosynthetic genes is a concept that is found for several defence chemicals [24] . The induction of CYP79B2 and CYP71B15 was investigated by promoter GUS (β-glucuronidase) analysis, and strong localized GUS expression was observed after silver nitrate spraying and infection with Pseudomonas syringae or Alternaria alternata [11, 16, 21] . The localized gene induction was quantified by RT (reverse transcriptase)-PCR and CYP79B2 and CYP71B15 transcript levels were highly elevated locally in the zone infected with Alternaria alternata. Similarly, tryptophan biosynthetic genes were highly induced, ensuring supply of sufficient substrate. Interestingly, CYP79B3 was induced only to a minor extent [21] . Generally, after infection with various pathogens, induction of CYP79B2 exceeded CYP79B3 induction, which is in accordance with a reduced camalexin content of cyp79b2 knockout mutant in response to silver nitrate or B. cinereae infection [11, 12] .
Conclusion
CYP enzymes are essential for many secondary metabolite pathways. This holds true for the biosynthesis of camalexin, where at least two P450 steps are involved (for an overview on Table 1 Properties of CYP79B2 and CYP71B15 [9, 11, 12, 16, 21] WT, wild-type. 
CYP79B2 CYP71B15

